Zobrazeno 1 - 10
of 225
pro vyhledávání: '"Yanning Liu"'
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Bach2 was initially discovered in B cells, where it was revealed to control the transcription involved in cell differentiation. Bach2 is intimately connected to CD8 + T lymphocytes in various differentiation states and subsets according to r
Externí odkaz:
https://doaj.org/article/234f53d4a57b4ac99abc4b9c1d9e3924
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1708 (2024)
The third-generation aromatase inhibitors (AIs), represented by letrozole, anastrozole, and exemestane, have been used as a standard first-line adjuvant therapy for postmenopausal breast cancer patients with positive hormone receptor. However, their
Externí odkaz:
https://doaj.org/article/b0ff4efce2274bf2b55bd3bc92d9eafc
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Mesenchymal stem cells (MSCs) have emerged as a promising alternative treatment for liver disease due to their roles in regeneration, fibrosis inhibition, and immunoregulation. Mitochondria are crucial in maintaining hepatocyte integrity and
Externí odkaz:
https://doaj.org/article/20127e367ce241269a04cd0bd78f7e67
Autor:
Shenghui Wu, Yanning Liu, Melanie Williams, Christine Aguilar, Amelie G Ramirez, Ruben Mesa, Gail E Tomlinson
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303725 (2024)
[This corrects the article DOI: 10.1371/journal.pone.0278354.].
Externí odkaz:
https://doaj.org/article/0c609a6e55ea46bd9ddbb3dbc4d0ef3e
Autor:
Yina Zhang, Liying Wang, Jiajia Shao, Yanning Liu, Yining Lu, Jing Yang, Siduo Xu, Jingkang Zhang, Minwei Li, Xiangrui Liu, Min Zheng
Publikováno v:
MedComm, Vol 4, Iss 5, Pp n/a-n/a (2023)
Abstract Calcipotriol (CAL) has been widely studied as a fibrosis inhibitor and used to treat plaque psoriasis via transdermal administration. The clinical application of CAL to treat liver fibrosis is bottlenecked by its unsatisfactory pharmacokinet
Externí odkaz:
https://doaj.org/article/4d964c9e7d4949db89180f2ce6c049b6
Autor:
Shenghui Wu, Yanning Liu, Melanie Williams, Christine Aguilar, Amelie G Ramirez, Ruben Mesa, Gail E Tomlinson
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0278354 (2023)
This study examines childhood cancer survival rates and prognostic factors related to survival in the majority Hispanic population of South Texas. The population-based cohort study used Texas Cancer Registry data (1995-2017) to examine survival and p
Externí odkaz:
https://doaj.org/article/0137b0df6fd24c2886cb4eeea7163d00
Publikováno v:
Metals, Vol 13, Iss 6, p 1011 (2023)
In this paper, the effect of batch-annealing temperature on the oxidation of 22MnB5 steel during austenitizing was studied. When the batch-annealing temperature was decreased from 690 to 680 °C, the surface roughness of cold-rolled 22MnB5 steel decr
Externí odkaz:
https://doaj.org/article/1b8f52baf5704640856f3fc59652161e
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-14 (2021)
Abstract Background Hepatocellular carcinoma (HCC) is one of the most common cancers with high incidence and mortality. However, the underlying mechanisms of HCC still remain unclear. Eukaryotic translation initiation factors (eIFs) have a substantia
Externí odkaz:
https://doaj.org/article/84f898f020584383ad16f9c4751d06f6
Publikováno v:
Cell & Bioscience, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Background Acute liver failure (ALF) is associated with a high mortality rate, and there are still no effective treatments except liver transplantation and artificial liver therapies. This study aimed to determine the effects, therapeutic wi
Externí odkaz:
https://doaj.org/article/a2dbe91873b14a3c80c110d09cb3ef6c
Publikováno v:
Cancer Control, Vol 29 (2022)
Objectives The objective of our study was to investigate and compare the epidemiologic characteristics, prognostic factors, and survival between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) patients. Methods Age-adjusted i
Externí odkaz:
https://doaj.org/article/8840f0b2684646cdad51177ac86b3039